Agafina, Alina; Aguiar, Valeria Cristina; Rossovskaya, Maria; Fartoukh, Muriel Sarah; Hajjar, Ludhmila Abrahão 
; Thiery, Guillaume; Timsit, Jean-Francois; Gordeev, Ivan; Protsenko, Denis; Carbone, Javier
Source: European Journal of Medical Research. Unidade: FM
Subjects: COVID-19, ESTUDOS MULTICÊNTRICOS, ESTUDOS RANDOMIZADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AGAFINA, Alina et al. Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID). European Journal of Medical Research, v. 29, n. 1, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/79450. Acesso em: 25 jan. 2026.APA
Agafina, A., Aguiar, V. C., Rossovskaya, M., Fartoukh, M. S., Hajjar, L. A., Thiery, G., et al. (2024). Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID). European Journal of Medical Research, 29( 1). doi:10.1186/s40001-024-02008-xNLM
Agafina A, Aguiar VC, Rossovskaya M, Fartoukh MS, Hajjar LA, Thiery G, Timsit J-F, Gordeev I, Protsenko D, Carbone J. Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID) [Internet]. European Journal of Medical Research. 2024 ; 29( 1):[citado 2026 jan. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/79450Vancouver
Agafina A, Aguiar VC, Rossovskaya M, Fartoukh MS, Hajjar LA, Thiery G, Timsit J-F, Gordeev I, Protsenko D, Carbone J. Efficacy and safety of trimodulin in patients with severe COVID-19: results from a randomised, placebo-controlled, double-blind, multicentre, phase II trial (ESsCOVID) [Internet]. European Journal of Medical Research. 2024 ; 29( 1):[citado 2026 jan. 25 ] Available from: https://observatorio.fm.usp.br/handle/OPI/79450
